ncRAN |
Upregulated |
Oncogenic |
[137] |
lncUSMycN |
Co-amplified with MYCN
|
Oncogenic; upregulates MYCN mRNA expression via binding to NonO |
[136] |
SNHG1 |
Upregulated |
Oncogenic; downregulates miR338-3p, leading to PLK4 overexpression |
[138] |
lncNB1 |
Upregulated |
Upregulates E2F1 expression by binding RPL35, leading to transcription of DEPDC1B
|
[139] |
NDM29 |
Downregulated |
Induces differentiation of MNA NB cells when overexpressed |
[140] |
T-UCRs (uc.347, uc.350, uc.279, uc.460, uc.379, uc.446 and uc.364) |
Upregulated |
Oncogenic; involved in proliferation, apoptosis, and differentiation |
[84] |
MYCNOS-01 |
Co-amplified with MYCN
|
Oncogenic; regulates MYCN protein expression |
[141,142] |
MYCNOS-02 |
Co-amplified with MYCN
|
Oncogenic; interacts with G3BP1 and recruits CTCF to the MYCN promoter, thereby increasing MYCN expression. Suppresses differentiation and increases growth, invasion, and metastasis of NB cells |
[141] |
circ_0003287, circ_0008083, circ_0052767, circ_0000978, circ_0117720, chr2:15467874|15567918, circ_0008261 |
Upregulated |
Oncogenic |
[41] |
circARID1A |
Upregulated |
Oncogenic; promotes proliferation and survival of NB cells via direct interaction with KHSRP |
[144] |